Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease. Barba L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al. J Neurol Neurosurg Psychiatry 2022 Aug 9. pii: jnnp-2022-329124.

Read + Share

Amedeo Smart

Independent Medical Education

Barba L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al. Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease. J Neurol Neurosurg Psychiatry 2022 Aug 9. pii: jnnp-2022-329124.
PMID: 35944974